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Abstract
We describe the use of conceptual DFT based quantum chemical molecular fields for three-dimensional
quantitative structure-activity relations (3D-QSARs) and compare this new approach with the
use of the default molecular property fields. The use of the new molecular fields in 3D QSAR is
investigated by an application in the field of drug discovery, in which the antituberculotic activity of
salycilamide derivatives is investigated. It is shown that conceptual DFT molecular fields have an
added value to the default considered CoMFA fields.
Keywords: 3D QSAR, Conceptual DFT
1. Introduction
There can be hardly any doubt that one of the main contributors to our current quality of life
has been the development of medicine, including the availability of modern drugs and treatments for
many health problems. It can moreover be expected that development of new drugs will continue
to be important for at least three reasons. First, there remain diseases that, despite having been
known for long time, remain without cure although they affect the quality of life of millions or even
billions of people. A typical example is malaria. Second, as life expectation continues to increase,
especially in the developed world, some diseases associated with high age become more abundant
and require treatment. Third, new diseases show up from time to time.
The development of new drugs is a very time consuming and error prone venture. One of the
reasons why is the enormous vast chemical search space where new ligands (i.e. substances that
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eventually can become drugs) have to be sought. From a theoretical/computational chemistry
perspective, one of the most promising ways for ligand design would rely on a detailed dynamical
description of the ligand/target interaction, including all the essential characteristics of the environ-
ment (solvent, electrolytes, ambient temperature, ...) [1]. At present such methods still need to be
developed much further to have a sufficient level of detail. Moreover, these methods are so time
consuming that they can hardly be used for ligand design where thousands of candidates need to be
evaluated.
An alternative to the detailed dynamical description of the interaction are Quantitative Structure
Activity Relationships (QSAR), a field of study introduced by Hammet [2], Hansch and Fujita [3]
and Free and Wilson [4]. The fundamental assumption for a QSAR is that variations in biological
activity among a set of compounds can be related to variations in their chemical structures and
properties. In practice one largely abandons the detailed dynamical interaction but tries to establish
a mathematical connection between the biological activity of a compound and some key molecular
properties. The actual mathematical connection relies on statistics and relates biological activity to
so-called molecular descriptors. Such descriptors range in complexity from very simple features like
molecular mass, via absence/presence data for e.g. specific functional groups, to full 3D molecular
fields like the electron density. The statistical method used then identifies those descriptors that give
the best QSAR based on a set of known data for biological activity and descriptors for a so-called
training set. Once the QSAR is known, it can then be used to predict the activity of molecules for
which only the descriptors are known.
In the present paper we examine how well 3D molecular fields from conceptual or chemical DFT
perform as descriptors for antituberculotic activity of salicylamides. Do they offer added value
compared to simpler descriptors? In order to answer this question, we first describe in some more
detail the QSAR algorithm used, then the fields considered and eventually the results of the QSAR
in detail.
2. Quantitative structure activity relationships
For the construction of QSAR models, most often a linear model is sought, which can be expressed
as equation (1)
A = k1 ∗D1 + k2 ∗D2 + ...+ const (1)
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Here A stands for the biological activity, Di stands for the value of the i
th molecular descriptor
retained in the QSAR, ki is the regression constant belonging to descriptor Di and C is a constant.
The core machinery of deriving a QSAR are statistical algorithms that pick the most discriminating
descriptors for each problem from a large pool of possible descriptors and yield the coefficients ki.
Obviously, in order to develop a QSAR, one first needs a set of molecules for which the activities
are known as well as a set of descriptors from which usually only a small fraction will be kept in
the final QSAR. Obviously, the better one can describe the molecule in terms of a set of molecular
descriptors, the bigger the chance of a better QSAR. As a consequence, there has been a lot of
research on the development of new descriptors that may be better at representing different aspects
of molecular behavior, e.g. reactivity [5]. Note that extending the pool of descriptors from which to
pick the significant descriptors for the problem considered is fruitful, provided the descriptors are
not correlated. Increasing the number of descriptors retained in the QSAR model has to be done
with great care in order to avoid overfitting and so is fundamentally different from increasing the
pool of descriptors.
2.1. Three-dimensional (3D) QSAR
In 3D-QSAR [6], one uses 3D molecular fields as molecular descriptors. Assuming that the
compounds considered in some application all bind in more or less the same way to the target, one
could use the value of a 3D molecular field at every point in space as a descriptor. If then one
assumes that variation in biological activity can be related to the change in these 3D molecular field
values between the molecules, a 3D-QSAR model can be obtained.
The first commercially available 3D QSAR algorithm is known as CoMFA [7], where the default
interaction fields are the steric and electrostatic fields, evaluated on a common grid of points. The
same grid is used for all molecules, so molecular alignment plays an important role. The Partial
Least Squares (PLS) technique [8] is used to handle the high number of descriptors.
3D QSAR models are relatively easily interpretable through visualization of where the important
regions that correspond to descriptors retained in the QSAR are located. Once it is known in what
region these reside and what effect they have on the QSAR, drug designers can manipulate the
ligand candidates to maximally exploit these regions and hence increase the (predicted) activity of
the compound.
CoMFA is still used very often as it does often give good working QSAR. Over the years, several
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workers have introduced several new types of fields, adding hydrophobic [9], hydrogen donor and
hydrogen acceptor [10] or lipophilic [11] information to the model. Our interest lies mainly in the use
of fields originating from so-called conceptual or chemical DFT [12]. The use of these fields is very
attractive in 3D QSAR, as they can be interpreted as reactivity indices representing the response
of a system to a perturbation[13]. In as far as the system modeled can be assumed to represent
the actual drug or ligand in its working environment, the biological activity could be expressed
completely in terms of the electron density, or the shape function, or the response functions such as
the Fukui function or the local softness.
In the next section the 3D fields are introduced. The final section presents the application for a
real test case.
3. 3D QSAR molecular property fields
3.1. Default considered CoMFA fields
In standard CoMFA, two fields are generated on a regular grid : the electrostatic and the steric
field. The electrostatic field at a point j is expressed as its approximate Coulomb point-charge based
potential function. The steric field is based on the Lennard-Jones potential function. Both fields are
extensively described in reference work about 3D QSAR [7].
3.2. Fields based on conceptual DFT
It is known that the insufficient representation of the investigated structures in CoMFA is
still an inherent deficiency in the algorithm, despite the widespread use and success of 3D QSAR.
Representing a molecule by a set of atom-centered partial charges to calculate its Coulomb interaction
is a very crude approximation, corresponding to the assumption that the charge distribution is
locally isotropic close to the atoms. As a consequence, the models do not always represent the
real situation. Therefore, together with the invention of the 3D QSAR technique, a search for new
descriptor fields originated as well.
The fields introduced here are obtained from conceptual density functional theory and are extensively
reviewed in reference [12]. The solid theoretical foundation of these fields does not stand any intuitive
interpretation in the way, which is important for use as QSAR descriptors.
The fundamental property in conceptual DFT is the molecular electron density ρ, which is related
to the shape and the size of a molecule. A molecular 3-dimensional descriptor closely related to
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the electron density is the shape function. The molecular shape function, or shape factor σ(r) as
introduced by Parr and Bartolotti in reference [14] characterizes the shape of the electron distribution
and carries relative information about its electron distribution as described in references [15, 16, 17].
The next field used in this study is the Fukui function, a 3-dimensional descriptor that allows
understanding and predicting relative reactivities of different sites in a molecule. Due to the
discontinuity in the ρ versus N curve, two fukui functions need to be distinguished [18, 19], where at
the point r, f+(r) and f−(r) are direct measures of reactivity toward nucleophilic and electrophilic
attack. That is, regions where f+(r) is large capably stabilize additional electron density and hence
are especially reactive towards electron-rich reactants. Regions where f−(r) is large readily give up
their electrons, and are thus reactive towards electron-poor reactants.
The final conceptual DFT field introduced in the 3D QSAR context is the local softness, which
describes the tendency of a particular site to be involved in “frontier-controlled” interactions [20].
As for the fukui function, two softness functions need to be distinguished. These has been shown to
play a key-role in the application of the HSAB principle at local level [21, 22], and has been used in
a variety of studies on regioselectivity [12].
3.3. Pretreatment of fields
It is well known in the QSAR methodology that a proper pretreatment of variables is crucial for
the outcome of the analysis.
Intrinsic to 3D QSAR, there are many grid points with only minor variation in the field values
throughout the compound set, e.g. the field values far outside the molecules. To eliminate such grid
points, a ‘minimum sigma’ condition is defined. The grid points with a variation in the field value
among the molecules lower than the minimum sigma value are not considered in the subsequent
PLS analysis.
Some fields, as the default CoMFA fields and the electron density, have in close proximity to the
surface of the atoms very steep slopes. It is common to truncate the field values at some arbitrary
level to eliminate these points. It is necessary to use only well investigated cutoff values as the
model quality depends critically on this value. Both the Fukui function and the softness field do
not require any cutoff, as they are computed as finite differences. Hence, the large extremes in the
unperturbed neutral system are compensated by nearly exactly the same extremes in the perturbed,
anion or cation, density function.
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4. Antituberculotic activity of Salicylamides : a 3D QSAR case study
4.1. Dataset
44 derivatives of salicylamides [23], with possible antituberculotic activity, are used for 3D QSAR
model development. All molecules have one of the five basic structures shown in figure 1, presented
together with the possible substituents R. The compounds cover a promising group of potential
drugs with a new, yet unrevealed, mechanism of action. They are assumed to serve as structural
templates of inhibitors of the two-component regulatory system in bacteria[24]. The derivatives of
salicylamides are tested for in vitro activity against Mycobacterium tuberculosis. As tuberculosis is
still a considerable illness causing the death of more than a million people a year, it remains a main
target for drug discovery. Analysis of structure-activity relationships of salicylamide derivates can
produce fruitful suggestions for further research of antituberculotics. Using computed properties of
the salicylamide derivatives we wish to identify the essential conditions depending on which the
compounds elicit a stronger/weaker biological response.
In vitro antimycobacterial activities of compounds 1 - 5 against Mycobacterium tuberculosis CNCTC
My 331/88 are taken from the literature[23]. The antimycobacterial activities of the compounds
are determined as minimal inhibitory concentrations (MIC) after incubation at 37 ◦C for 14 days.
The concentrations of the compounds applied in the assay are 1000, 500, 250, 125, 62.5, 32, 31,
16, 8, 4 and 2 µmol/l, giving rise to a discrete character of MICs. The activities for the tested set
of molecules are presented in table 1, with the compound name composed corresponding to the
numbering of the basic structures and the name of the substituents in figure 1.
4.2. Algorithmic details
Any 3D QSAR analysis requires a list of algorithms and parameters which all need to be
established beforehand. These are all investigated in depth in reference [25] and the final selected
algorithms and parameters will be summarized here.
Starting from the set of molecules, a subset of compounds is selected as a training set by K-means
clustering [26]. The test set contains five molecules, indicated with an asterisk in table 1.
6
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Figure 1: Molecular set investigated for antituberculotic activity.
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Table 1: Biological activities for the molecular set tested for antituberculotic activity on Mycobacterium
tuberculosis. Molecules constituting the test set are indicated by an asterisk.
MIC -log(MIC)
1b 62.5 4.20
1c 31 4.51
1d 16 4.80
1e 8 5.09
1f 16 4.80
1g 62.5 4.20
1h* 31 4.51
1i 8 5.09
1j 8 5.09
1k 16 4.80
1l 62.5 4.20
2a 250 3.60
2b 125 3.90
2c 62.5 4.20
2d 62.5 4.20
2f 62.5 4.20
2g 125 3.90
2i* 32 4.50
2l 125 3.90
3a 500 3.30
3c 125 3.90
3d 125 3.90
MIC -log(MIC)
3e 62.5 4.20
3g 250 3.60
3i 125 3.90
3j* 125 3.90
4a 32 4.50
4b 16 4.80
4c 32 4.50
4d 32 4.50
4e 62.5 4.20
4f 62.5 4.20
4g* 16 4.80
4h 32 4.50
4l 16 4.80
5a 8 5.09
5b 8 5.09
5c 8 5.09
5d 8 5.09
5e 32 4.50
5f 8 5.09
5g 8 5.09
5j* 8 5.09
5k 8 5.09
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The molecular structures have been geometry optimized at the DFT level using the B3LYP
functional and 6-31G* basis set as implemented in Gaussian03 [27].
As the electrostatic field is calculated as an atomic point charge approximation, an optimal
partial point charge calculation scheme has to be selected. Several charge calculation methods has
been investigated in [25], as the partial charges derived from Gasteiger-Marsili[28, 29], the MMFF94
force field [30], Mulliken population analysis [31], Natural population analysis [32], Hirshfeld analysis
[33] and the iterative Hirshfeld analysis [34]. It was found that simpler methods, such as the
Gasteiger-Marsili method, yield results of good quality, and thus can confidently be used to construct
the electrostatic field.
There is no structural information available on the target or receptor environment. As a
consequence, the alignment is restricted to these algorithms which do not make use of any information
about the target. The molecular set is subjected to different so called ligand-based alignment
techniques, in order to select the most promising alignment [25]. Out of several alignment techniques
(TGSA[35], ROCS[36] and QSSA[37]), the ROCS algorithm implemented in the Openeye Software
Suite [38] performed the best. ROCS stands for ‘rapid overlay of chemical structures’, a rigid body
optimization process that maximizes the overlap volume between the compounds.
For the default CoMFA studies, with the electrostatic and steric field only, a spacing of 1 A˚ in a
box extending to 4 A˚ outside the molecular van der Waals surface is preferred in order to have
an accurate description of the field. These values are selected throughout history as the set of
values that invokes a good and consistent CoMFA outcome. As there has been a limited number of
preceding studies on the optimal parameters for quantum chemical fields [39, 40], it was necessary
to set-up a study for the optimal spacing for these conceptual DFT quantum chemical fields. For
this set of molecules, a grid spacing of 0.6 A˚ in a box extending to 1 A˚ outside the molecular
van der Waals surface can be advocated. The current parameters are chosen as a balance between
computational expense and consistent outcomes.
Each of the fields - except the Fukui function and the softness field - need to be allocated a
cut-off value, as specified before. An optimal cut-off value can be found by scanning the performance
of the models, slightly varying the cut-off value from a minimum to a maximum value. The optimal
cut-off values are mentioned in table 2.
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Table 2: 3D QSAR model cut-off values.
Model Field |Cut-off value|
1 ρ(r) 1.07 bohr−3
2 σ(r) 0.03 bohr−3
3 f+(r) No Cut-off
4 f−(r) No Cut-off
5 s+(r) No Cut-off
6 s−(r) No Cut-off
7 Electrostatic potential 36.9 kcal
mol
8 Steric potential 30.1 kcal
mol
4.3. Results
The default molecular interaction and the quantum chemical molecular fields are subjected to
a cross-validated 3D QSAR analysis. The models are obtained in a PLS model building with a
leave-10-out cross-validation. The results are summarized in table 3. The quality of a QSAR model
is characterized by its complexity, i.e., the number of latent variables (LV) necessary to describe the
dataset and by the quality of prediction, the predictive correlation coefficient q2 obtained by the
leave-10-out procedure (q2L10O). A value higher than 0.50 indicates a model with predictive capacities.
Table 3: 3D QSAR model characteristics.
Model Field LV q2L10O
1 ρ(r) 4 0.68
2 σ(r) 2 0.69
3 f+(r) 4 0.68
4 f−(r) 2 0.75
5 s+(r) 4 0.67
6 s−(r) 2 0.76
7 Electrostatic potential 4 0.66
8 Steric potential 3 0.65
Model 6 using the softness s− field as independent variable is, based on the internal predictive
power, statistically the most significant within the set of quantum chemical fields. The model can
be set up successfully using only two latent variables. In order to make a fair comparison between
the classical and the quantum chemical approach for the problem, a full statistical analysis has been
performed for model 6 as well as for the two default CoMFA fields (model 7 & model 8). The results
are summarized in table 4. The number of latent variables and the predictive power are repeated
from the previous table, the goodness-of-fit is given by R2. The internal predictivity test indicates
10
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the predictivity of the model, but the only true test on the predictive power of a model can be
obtained through the application of the final model on the external test set and is quantified by the
value of q2ext and the root mean square error (rmse) on the predicted values.
Table 4: Statistical parameters for selected models
Model LV R2 q2L10O q
2
ext rmse
6 2 0.81 0.76 0.77 0.22
7 4 0.80 0.66 0.88 0.16
8 3 0.84 0.65 0.89 0.14
4.4. Discussion
4.4.1. Behavior of the Quantum chemical fields
As 3D QSAR results are primarily judged based on the predictivity, the quantum chemical fields
will primarily be compared with each other based on the q2L10O value. The fields presented in the
first part of table 3 can all be classified as predictive. Especially the f− and s− fields yield promising
results. The electron density gives a model with a lower predictivity. The shape function gives a
slightly more predictive model than the electron density at a lower number of latent variables, but
the improvement in quality is rather small. This is not surprising as the molecules in the training
set are of similar size and thus of comparable electron number. Therefore, the extra information
included in the shape function disappears.
The fact that the Fukui f− and the softness s− fields give predictive models at only 2 latent variables
can be a hint towards the mechanisms of action. Both fields indicate an electrophilic attack from
the receptor towards the ligands.
4.4.2. Comparison of 2D QSAR and 3D QSAR
Another well investigated kind of QSAR analysis is 2D QSAR. In contrast to 3D QSAR, 2D
QSAR does not make use of local field descriptors. As a consequence, far less number of descriptors
are fed into the analysis, which simplifies the statistics to multiple linear regression.
It is clear that 2D QSAR - by its very nature - is much more straightforward than 3D QSAR. More
user intervention is necessary in each step in 3D QSAR. As the current set of molecules has been
investigated in a 2D QSAR analysis[41], a comparison can be made between 2D QSAR and 3D
QSAR. The results for the 2D QSAR analysis are summarized in table 5, together with the 3D
QSAR analysis results. Despite the fact that the 2D QSAR analysis was performed without an
11
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Table 5: Comparison between 2D QSAR and 3D QSAR models. The 2D QSAR model is based on 45
molecules, no test set is selected. The 3D QSAR models are based on 39 molecules, with a test set of 5
molecules.
2D QSAR 3D QSAR
Model 6 7 8
Number of molecules 45 39 39 39
Goodness-of-fit 0.91 0.81 0.80 0.84
Number of descriptors 5 2 4 3
Internal predictivity 0.89 0.76 0.66 0.65
External predicitivity / 0.77 0.88 0.89
external test set, the internal predictivity and the goodness-of-fit indicate the superiority of the 2D
QSAR model. Based on the results presented, one would favor 2D QSAR model for the current
problem.
The mechanistic interpretation of the 2D QSAR model indicates electrostatic interactions at some
points [41]. And at this point, the 3D QSAR models are favored on the 2D QSAR models as with
these models one can pinpoint the exact locations where the electrostatic interactions with the
environment are favored.
Thus based on the simplicity and the statistical parameters, one would favor the 2D QSAR model
building, but the 3D QSAR models still have their own benefit as they give a 3-dimensional
interpretation of the results.
4.4.3. Comparison of the Default CoMFA and the Quantum chemical models
As new fields are introduced in 3D QSAR, their performance has to be compared with the
performance of the classical fields in CoMFA, in order to investigate whether these fields are worth
the effort to calculate for future applications. Therefore the most promising quantum chemical 3D
QSAR model, the model based on the s− (model 6), will be highlighted and confronted with the
models based on the default CoMFA fields (model 7 & model 8) and tested on some essential QSAR
conditions, published as preliminary guidelines from the European Commission in reference [42].
Table 4 summarizes the statistical results for the three models.
Robustness : A clear correlation between the chosen descriptors and the target property, as can be
seen by the goodness-of-fit, R2, is apparent. The three models have a similar behavior concerning the
goodness-of-fit, so no distinction can be made between the fields based on this one statistical criterion.
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Predictivity : The main goal of any QSAR is the prediction of the activity of new compounds, so
the internal predictivity is an important criterion. In table 4 it is clear that the internal predictive
capacity of the model with the quantum chemical field, softness s−, is higher than for both default
considered CoMFA fields. The application of the models on the external test set of compounds
establishes the real predictive power of the model. However, the external test set may not be
involved in the model building at any point. Thus the results on the external test set may not
be used in any decision-making about the superiority of one field over the others, but only as an
external confirmation of the predictive power of a model. Based on these external results, the three
fields all give rise to predictive models.
Explanatory power : Knowledge about the explanatory power enables the user to suggest a
possible mode of action for the active compounds and to propose ameliorations on possible future
ligands. A graphical analysis of the coefficient fields is given in figures 2-4. These give a rough
location from which structure activity relationship statements can be inferred, discriminating areas
where fields are important from those that have no significance. Positive values for the steric field
(orange) in figure 2 indicate areas where an increase in steric hindrance would produce higher activity,
and areas showing negative values (green mesh) are those where steric bulk would decrease the
activity of the ligands. Positive values for the electrostatic field (red mesh) in figure 3 indicate
those areas where a highly positive electrostatic potential would produce higher activity, promoting
electropositive ligands at these sites. Areas showing negative values (blue) are those where a highly
negative electrostatic potential would increase the activity, thus promoting electronegative ligands
at these sites. The coefficients for the softness field are given in figure 4. While the electrostatic
potential indicates those regions that an electrophile or an nucleophile is likely to approach, it is
also important to know how readily available the electrons in those regions are. The map of the
softness function indicates the susceptibility to electrophilic or nucleophilic attack. Positive values
(green) for the softness s− map indicate those areas where an electron-rich center would increase
the activity. Negative values (yellow mesh) for the softness map indicate those areas where an
electron-rich center would decrease the activity. It is thus clear that the three fields considered all
can be interpreted readily for the problem at hand.
13
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Figure 2: Stdev*coeff map showing areas of favorable and unfavorable steric field contributions to the
activity.
Figure 3: Stdev*coeff map showing areas of electrostatic field contributions to the activity.
Figure 4: Stdev*coeff map showing areas of softness field contributions to the activity.
14
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Table 6: Summary of conditions for QSAR model building, applied on model 6, 7 & 8
Model 6 Model 7 Model 8
Robustness + + +
Predictive power
Internal ++ + +
External + ++ ++
Explanatory power + + +
Simplicity
Computer time - + +
Uniqueness + - -
Simplicity and Uniqueness : The fact that both CoMFA fields are much easier to calculate than
the quantum chemical fields in 3D QSAR, favors them clearly. The screening of the molecular set of
39 molecules takes 1 minute for both classical fields on one computer and 5 minutes for the softness
field on a cluster of 20 computers. However, the main drawback of the default considered CoMFA
field is their lack in uniqueness, due to the variable parameters that constitute their expression, as
e.g. the plethora of possibilities in calculating the condensed charges.
Gathering these four criteria together, it is clear that none of the 3D fields can be favored above
the other fields. The three models behave well for the conditions mentioned, as is summarized
in table 6. Thus, although the default 3D QSAR fields are useful in obtaining predictive 3D
QSAR models for the current problem, the quantum chemical approach is worth the effort, due to
the extra information obtained and the uniqueness in obtaining and using the quantum chemical field.
The 3D QSAR results can be ameliorated by combining several 3D molecular fields into one
model. As the main purpose of the current article was to indicate the usefulness of individual
quantum chemical fields in 3D QSAR, we do not pursue this further but rather refer the reader to
Van Damme et al. [43] for an example where different fields are combined.
5. Conclusion
In this study the behavior of the default CoMFA fields is confronted with the conceptual DFT
fields in 3D QSAR analysis. Properties like electron densities or Fukui functions for electrophilic
and nucleophilic attack can be used as physically meaningful descriptors. The example indicates
that the newly introduced fields are worth the effort to be used in 3D QSAR problems as they can
15
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have a similar behavior compared to the default 3D QSAR field and they deliver new interpretable
information, not included in the default 3D QSAR fields. Especially in those cases where the default
considered CoMFA fields do not carry the necessary information for a predictive 3D QSAR model,
it is our advise that conceptual DFT quantum chemical fields should be considered.
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